Logo image
Sign in
3 Oral: Tucatinib and Trastuzumab for Patients With Previously Treated, HER2- Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
Journal article   Peer reviewed

3 Oral: Tucatinib and Trastuzumab for Patients With Previously Treated, HER2- Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study

Y. Nakamura, T. Bekaii-Saab, E. Hamilton, H. Hayashi, N. Mizuno, B.J. Monk, D. Nguyen, A. Okines, D.M. O’Malley, P.R. Pohlmann, …
European journal of cancer (1990), Vol.211, p.114532
10/2024

Metrics

1 Record Views

Details